Evidenced by the move to measure and reimburse providers based on the quality, as opposed to the quantity, of care delivered, the healthcare industry is shifting from a fee-for-service to an outcomes or value-based model.
For the 11th year, Med Ad News selected new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Much has been written about the supposed “death of the sales rep.” Digital disruption, declining rep access to physicians, and the increasing appetite of healthcare providers for readily available digital information have led some industry observers to suggest that the traditional field sales role might one day become obsolete. But while the role is certainly changing, the industry shift towards intelligent engagement means the sales rep will prove more valuable than ever.
Change is inevitable, and evolving and growing with it is the only way to move forward. That’s just a fact. Those in our industry who aren’t willing to embrace the constant changes we’re seeing in technology, trends, and now how we market health and wellness brands, are going to be left behind because journal ads, banner ads and TV commercials as exclusive mediums will likely not sufficiently reach a brand’s target audiences any longer.
Most health plans are covering at least one of the two biosimilar products currently on the market, according to new research by the strategic advisory company Avalere.
Despite the general anxiety over the impact of President Trump’s policies, when it comes to pharmaceutical sales forces, little of what he does will actually affect pharma sales-force strategies. The trends that are continuing to play out are declining rep access, the size of pharma sales forces, and the struggle with the concept of key account management, as well as trying to figure out how reps should be compensated.
By Robert Palmer Last week’s Coalition for Healthcare Communication (CHC) summit in Washington, D.C., was an interesting post-mortem of the 2016 election, and a look into the crystal ball by […]
Med Ad News’ first edition of the Pharma Leaders of Innovation special feature showcases two CEOs focusing outside the big pharma box and an agency tech leader.
To build brands in this most personal of industries, healthcare marketers must first make the human connection.
Understanding the nuances of your brand’s healthcare professional audience(s) can improve marketing strategies and make your media dollars work harder.